Fielmann AG (FLMNF)
Fielmann AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Hamburg, HA, DE. The stock last traded at $50.75, up 0.00% on the session, giving a market capitalisation of $4.26B. On trailing twelve-month figures it carries a trailing P/E of 16.48, a net margin of 8.4%. Its beta of 0.62 implies it has historically moved less than the broad market.
Fielmann Aktiengesellschaft, together with its affiliated companies, specializes in both investing in and operating businesses within the optical and audiological sectors. The firm is responsible for the production and sale of a wide array of visual aids, including spectacles, frames, corrective lenses, sunglasses, contact lenses, and their associated accessories, along with various other general merchandise. Additionally, Fielmann provides hearing aids and their complementary accessories. By December 31, 2021, the company had established a significant retail presence, managing 693 stores across Europe. This extensive network comprised 610 outlets in Germany, 45 in Switzerland, 38 in Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and an additional 15 locations spread throughout the rest of Europe. Furthermore, Fielmann operated 78 smaller retail points specifically in Eastern Europe. Beyond its physical stores, the company also makes its product selection available through online retail channels. Established in 1972 and based in Hamburg, Germany, Fielmann Aktiengesellschaft operates as a subsidiary under the ownership of Korva SE.
Fielmann AG is most often compared with the following Healthcare names: